Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this pilot study is to determine the impact of caffeine-enhanced energy drinks on blood glucose excursion on heart rate, blood pressure, cardiac output and cognitive performance in patients with type 1 diabetes.
Knowledge acquired may inform a wider study of the impact of these drinks.
This is a randomised, cross over blinded study in which all participants will participate in the 3 arms of the study.
The study will consist of 3 phases, each lasting 3 days. A different study drink will be administered during each phase. There will be an initial screening visit and a pre- study visit before each study phase. Each participant will make 10 visits to the research centre.
There will be a week wash out period between each study phase. Prior to each study phase, there will be a 3 day caffeine and alcohol abstinence run-in period.
Study drinks will be matched for taste and volume (as far as possible) and will be administered by the use of opaque cups, lids and straws to enable double-blind randomisation for both researcher and participants. Administration of the study drink to participants will be based on Latin squares to provide a balanced treatment order.
During the 3 days study period; participants will be required to abstain from all other caffeine containing beverages or confectioneries.
The secondary aim is to determine if tolerance to cardiovascular effects of caffeine-enhanced energy drinks is developed following acute short term ingestion.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Regular caffeine enhanced energy drink | Experimental | Regular caffeine enhanced energy drink (containing 240mg caffeine & 84g glucose) e.g. regular red bull cans (x3) |
|
| Diet Caffeine enhanced energy drink | Experimental | Diet Caffeine enhanced energy drink ( containing 240mg of caffeine alone) e.g. Red Bull light) |
|
| Glucose drink | Active Comparator | Glucose drink (containing 84g glucose alone) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Caffeine enhanced energy drink | Other | Comparison of different energy drinks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in blood glucose level in all patients as a measure of tolerability | Day 1, Day 2 and Day 3 |
| Measure | Description | Time Frame |
|---|---|---|
| The effects on certain mood states, e.g. energetic arousal, tense arousal and hedonic tone following the consumption of caffeinated energy drinks in comparison with caffeine free glucose in patients with type 1 diabetes | Day 1, day 2 and day 3 | |
| Changes in reaction time and digit symbol substitution test score |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tolulope Olateju, MRCP | The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust | Bournemouth | Dorset | BH7 7DW | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Glucose drink | Other | Glucose drink (containing 84mg glucose alone) |
|
| Day 1, day 2 and day 3 |
| Changes in heart rate, systolic and diastolic blood pressure in all patients. | Day 1, day 2 and day 3 |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |